Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of AOP Orphan.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
AOP Orphan
Austria Flag
Country
Country
Austria
Address
Address
Wilhelminenstraße 91/IIf 1160 Vienna
Telephone
Telephone
+43 1 503 72 44-0
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The Company will support the submission of a new drug application to the U.S. FDA seeking approval for Landiolol for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter.


Lead Product(s): Landiolol Hydrochloride

Therapeutic Area: Cardiology/Vascular Diseases Product Name: LDLL600

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Eagle Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: $5.0 million

Deal Type: Licensing Agreement August 09, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY